Risk factors for periorbital dermatitis in patients using dorzolamide/timolol eye drops

This study assessed the clinical risk factors for periorbital dermatitis (PD) after using dorzolamide/timolol eye drops in a total of 1282 glaucoma patients. Both the PD(+) group and the PD(−) group were evaluated using clinical data such as age, sex, dosing duration, presence of benzalkonium chlori...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Myungjin, Jang, Hyoju, Rho, Seungsoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429663/
https://www.ncbi.nlm.nih.gov/pubmed/34504268
http://dx.doi.org/10.1038/s41598-021-97565-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429663/
https://www.ncbi.nlm.nih.gov/pubmed/34504268
http://dx.doi.org/10.1038/s41598-021-97565-0

Ejemplares similares